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Abstract  Objective: To determine the validity and reliability of TranQol questionnaire that has been translated into Indonesian to be used in Indonesian thalassemia major patients. The quality of life problems among these patients can be detected earlier because TranQol is more precise compared to the Pediatric Quality of Life Inventory (PedsQLTM), World Health Organization Quality of Life Instruments (WHOQOL), and SF-36 Questionaire.
  Methods: This study was conducted in Bandung, Indonesia from October 2015 to March 2016 and used a standard “forward-backward” translation procedure. It involved 60 adults and 73 children who are thalassemia major patients, and 71 parents of patients in Dr. Hasan Sadikin General Hospital. TranQol was processed through forward and backward translation approach and evaluation was conducted by the TranQol author. After the translation 
process, a cognitive debriefing was performed and the translated TranQol was tested to all subjects.
 Results: Cronbach’s alpha >0.7 was used for all TranQol categories. Front validity and content validity testing was performed. The internal validity results showed that some questions were not valid.
 Conclusions: TranQol reliability in Indonesian language for every category is good. Validity for TranQol in Indonesian language shows that the translated TranQol is not quite suitable that it still cannot be used.  Keywords: TranQol Indonesia, validity Indonesia, reliability Indonesia
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Introduction Thalassemia is a monogenic disease that is caused by the disturbance in the hemoglobin formation that is observed around the world.1 India has alpha thalassemia cases of 12.9% and beta thalassemia cases of 3–4%.2,3 Beta thalassemia is mostly found in Mediteranian countries, Middle East, Middle Asia, India, South China and countries along North Africa and South America beach.4 The Indonesian Thalassemia Foundation-Association of Thalassemia Patients’ Parents or known as YTI-POPTI (Yayasan Thalassemia 
Indonesia-Perhimpunan Orang Tua Pasien 
Thalassemia) has reported increased number of thalassemia patients in Indonesia to 7,028 in 2015.5 The prevention of thalassemia is 
difficult because of its genetic nature. Blood transfusion and iron chelating agent increase the survival rate of thalassemia major patients. They will have more opportunities to reach higher education, to work, and to have a better quality of life. In addition, patients may experience complications from the procedure (i.e: osteoporosis, infertility and psychiatric problem). Iron absorption problem in guts and blood transfusion can lead to chronic health problems due to iron acumulation in the body. These will affect thalassemia patients’ quality of life. Research has been done in many countries to evaluate thalassemia patients’ quality of life. 
Received:May 5, 2017Revised:July 21, 2017Accepted:August 30, 2017
:75–9
76 International Journal of Integrated Health Sciences. 2017;5(2)
Some questionnaires are already used to assess it, such as Pediatric Quality of Life Inventory (PedsQLTM), the World Health Organization’s Quality of Life Instruments (WHOQOL), and SF-36 Questionaire.6–11 These are not specific enough for thalassemia patients.TranQol was created and published on July 22, 2013. TranQol is a self-report  tool used in children, adult, parents or proxy.12,13 There are 4 groups of questions in this tool: physical health, emotional health, family, school and career. There is only one question regarding the sexual aspect in this tool. The original TranQol have been evaluated for its reliability and validity. It is already acknowledged as a 
valid and reliable tool to be used specifically for thalassemia patients. Original English TranQol cannot be used in Indonesia because the different interpretation will reduce its validity and reliability. Hence, its has to be translated and evaluated for its validity and reliability before it can be used in Indonesia.
Methods A standard forward and backward translation procedure was performed by native speakers for the source and target languages after approval was gained from the  author and Mapi Research Institute. The procedure was based on Linguistic Validation of a Patient Reported Outcome Measure guideline. After 
that, a cognitive debriefing was conducted. The result was consulted to the author. The 
final TranQol in Indonesian language was then distributed for a try out among thalassemia patients. This involved 60 adult and 73 child thalassemia major patients and 71 parents, as proxy, who were selected randomly. The study has received ethical approval from the Ethics Committee of Dr. Hasan Sadikin General Hospital, Bandung and  Health Research Ethics Committee Faculty of Medicine Universitas Padjadjaran.The statistical analyses were performed using a computerized program. Cronbach’s alpha was used to assess  the reliability and the internal consistency of the questionnaire. Validity was evaluated using the Spearman correlation.
Results The mean age of the respondents in this study was 12.60 for children, 23.34 for adults, and 39.87 for parents and proxy. Blood 
transfusion frequency (in weeks) for children was 3.73 and 4.95 for adults. The reliability of TranQol in Indonesian language was tested by Cronbach’s alpha. The reliability was proven good with >0.7 Cronbach’s alpha for children, adults, parents, and proxy (i.e. 0.806 for child, 0.877 for adult, 0.926 for parent, and 0.755 for proxy).Validity  was tested by correlating each with the total score. TranQol in Indonesian validity testing included all 38 questions for parents but not included 9 of 28 questions in children, 10 of 36 questions for adults, 12 of 28 questions for proxy because those questions were left blank. This interfered the correlation with total score. Those unanswered questions could be not included in the evaluation based on the result of a discussion with the author of TranQol (Table 3 and 4).
DiscussionThe questions in the TranQol are more targeted for thalassemia patients when compared to Pediatric Quality of Life Inventory (PedsQLTM), the World Health Organization Quality of Life Instruments (WHOQOL), and also the SF-36 Questionaire. Some questions in the TranQol ask about the direct impact of thalassemia to the patients’s life. The impact of regular transfusion and iron removal treatment that 
are specific for thalassemia were asked too. The 
benefit is that thalassemia patients’s quality of life problems can be detected earlier, making early intervention possibler for optimal result.TranQol in Indonesian language for children did not include all questions. Questions 3, 6, 7, 8, 12, 13, 18, 22 and 23 are excluded. Question number 3 is about pain, 6 is about social activity, 7 is about painful examination, 18 is about negative effects of thalassemia, 22 and 23 are about decision of thalassemia care 
which were considered not specific and hard to be understood by children. 
Table 1 Subject Characteristics
Children Adult Parent or ProxyN 73 60 71Mean 12.60 23.34 39.87Median 13 22 39Minimum 7 19 23Maximum 17 39 62
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Question number 8 about feeling different from others, 12 about feeling angry, 13 about feeling sad are subjective and cannot be well understood by children under 10 years of age.TranQol in Indonesian language for adults did not include questions 10, 15, 24, 25, 31, 32, 33, 34, 35, and 36. Question number 10 about thlassemia impact in preventing activity, 15 about feeling anxious, 24 about feeling different with others were viewed to be not 
specific enough to be understood that it was decided not to include them in the Indonesian version of TranQol.Question 25 about sexual aspect was not answered by many participants because many respondents were not married yet or they consider the question is too sensitive from the perspective of Indonesian culture, which considers discussion on sexual topic as taboo. Questions number 31, 32, 33 on school and 34, 35, 36 on work were not answered by many respondents because most of them did not continue their education to the higher education level or work due to their disability.
TranQol in Indonesian language for proxy did not include questions 3, 6, 16, 17, 19, 20, 21, 24, 25, 26, 27, and 28. Question number 3 on pain felt by patient, 6 on social activity, 16 family support, and 17 on friends support were 
considered to be not specific so they would be hard to answer. Questions number 19, 20, 21 on relation between patient and his/her family were not answered because proxy did not have exact knowledge, patient had lost his/her parents, or patient was not carried by his/her parent anymore. Parents were also considered proxy that it may lead to confusion. Question number 24 regarding the child opinion about family economic problem was not answered by many because they did not know the answer or the children were too young to have opinion about it. Question number 25, 26, 27, 28 about school are not relevant for those who do not get higher education.All questions in the Indonesian version of TranQol for parents were well understood and answered well by all the respondents.Spearman correlation analysis was done :75–9
Table 2 Internal Validation for Children and Proxy
Children Spearman (R)  p Value Proxy
Spearman 
(R) p ValueQuestion 1   and score 0.228 0.052 Question 1  and score 0.5919 0.0000Question 2  and score 0.531 0.000 Question 2  and score 0.5550 0.0000Question 4  and score 0.431 0.000 Question 4  and score 0.6481 0.0000Question 5  and score 0.563 0.000 Question 5  and score 0.7570 0.0000Question 9  and score 0.442 0.000 Question 7  and score 0.5764 0.0000Question 10  and score 0.604 0.000 Question 8  and score 0.6085 0.0000Question 11  and score 0.593 0.000 Question 9  and score 0.6007 0.0000Question 14  and score 0.594 0.000 Question 10  and score 0.6619 0.0000Question 15  and score 0.332 0.004 Question 11  and score 0.5892 0.0000Question 16  and score -0.017 0.885 Question 12  and score 0.6237 0.0000Question 17  and score 0.266 0.023 Question 13  and score 0.7498 0.0000Question 19  and score 0.122 0.304 Question 14  and score 0.7178 0.0000Question 20  and score 0.519 0.000 Question 15  and score 0.4486 0.0001Question 21  and score 0.379 0.001 Question 18  and score 0.4660 0.0000Question 24  and score 0.515 0.000 Question 22  and score 0.3997 0.0006Question 25  and score 0.743 0.000 Question 23  and score 0.2985 0.0121Question 26  and score 0.669 0.000Question 27  and score 0.578 0.000Question 28  and score 0.509 0.000
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Table 3 Internal Validity for Adults and Parents
Adult Spearman (R)  p Value Parent
Spearman 
(R) p ValueQuestion 1 and score 0.168 0.203 Question 1 and score 0.2599 0.0286Question 2 and score 0.056 0.670 Question 2 and score 0.4118 0.0004Question 3 and score 0.486 0.000 Question 3 and score 0.3286 0.0051Question 4 and score 0.399 0.002 Question 4 and score 0.5990 0.0000Question 5 and score 0.479 0.000 Question 5 and score 0.5503 0.0000Question 6 and score 0.115 0.386 Question 6 and score 0.1765 0.1438Question 7 and score 0.593 0.000 Question 7 and score 0.2694 0.0231Question 8 and score 0.491 0.000 Question 8 and score 0.5901 0.0000Question 9 and score 0.394 0.002 Question 9 and score 0.5800 0.0000Question 11 and score 0.546 0.000 Question 10 and score 0.6397 0.0000Question 12 and score 0.514 0.000 Question 11 and score 0.6187 0.0000Question 13 and score 0.541 0.000 Question 12 and score 0.5030 0.0000Question 14 and score 0.452 0.000 Question 13 and score 0.5341 0.0000Question 16 and score 0.272 0.037 Question 14 and score 0.4115 0.0004Question 17 and score 0.049 0.711 Question 15 and score 0.5333 0.0000Question 18 and score 0.681 0.000 Question 16 and score 0.5017 0.0000Question 19 and score 0.719 0.000 Question 17 and score 0.5155 0.0000Question 20 and score 0.500 0.000 Question 18 and score 0.4975 0.0000Question 21 and score 0.669 0.000 Question 19 and score 0.7320 0.0000Question 22 and score 0.693 0.000 Question 20 and score 0.5324 0.0000Question 23 and score 0.203 0.120 Question 21 and score 0.5931 0.0000Question 26 and score 0.181 0.166 Question 22 and score 0.4294 0.0002Question 27 and score 0.522 0.000 Question 23 and score 0.6494 0.0000Question 28 and score 0.438 0.000 Question 24  and score 0.5892 0.0000Question 29 and score 0.453 0.000 Question 25  and score 0.2858 0.0165Question 30 and score 0.577 0.000 Question 26  and score 0.3312 0.0281Question 27 and score 0.5150 0.0000Question 28 and score 0.5376 0.0000Question 29 and score 0.6093 0.0000Question 30 and score 0.6099 0.0000Question 31 and score 0.5402 0.0000Question 32 and score 0.2301 0.0572Question 33 and score 0.1870 0.1212Question 34 and score 0.6671 0.0000Question 35 and score 0.5765 0.0000Question 36 and score 0.5977 0.0000Question 37 and score 0.5089 0.0000Question 38 and score 0.6412 0.0000
Quality of Life in Thalassemia Major: Reliability and Validity of Indonesian Version 
of the TranQol Questionnaire
:75–9
International Journal of Integrated Health Sciences. 2017;5(2) 79
for every question with the total score after selection of questions. Results of correlation analysis in this study show that 2 questions in TranQol for children are not valid (Table 3). Question number 16 about family support 
seems to be not specific so that it is difficult to answer. Question number 19 about decision on treatment is too hard to be understood by children and they usually follow their parents’ decision. Question number 6 in TranQol for adult is not valid. Question number 1 on sleep 
difficulty, 2 on pain, 6 on ability to do activity, 17 on telling thalassemia to others, 23 on guilty feeling when do not follow the treatment will 
be better understood if they are simplified and 
made more specific. Question number 6 on 
feeling disturbed by their child treatment and number 33 on support from friends might be 
difficult to understand due to their unspesific nature. All selected TranQol questions for proxy are valid.In conclusion, the reliability of Indonesian version TranQol is good but many questions from each category are still not valid. Further studies are needed to validate the translated TranQol before it can be used in Indonesia. It can be considered to translate TranQol by 
a certified translator. TranQol for proxy has the highest number of unanswered questions. Decreased concentration and motivation may be caused by the fact that parents had to answere TranQol for proxy in succession. 
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